Doctor Tamas Gergely
Gottsegen National Cardiovascular Center, Budapest (Hungary)
Prior cardiac ischemic injury exacerbates immune checkpoint inhibitor-induced cardiotoxicity
Event: Frontiers in CardioVascular Biomedicine 2024
Topic: Heart Failure
Session: Cardiotoxicity, cardiac fibrosis and metabolic cardiomyopathy
Immune checkpoint inhibition with PD-1 inhibitor induces cardiac dysfunction without overt myocarditis in C57BL/6J mice
Event: Frontiers in CardioVascular Biomedicine 2022
Topic: Drugs, Drug Targets
Session: Moderated poster 1 AWARD
ESC 365 is supported by
